<DOC>
	<DOCNO>NCT02015273</DOCNO>
	<brief_summary>This Multinational , Multicenter , Observational Study evaluate Adherence Long Term Outcomes Therapy pediatric subject use easypod™ electromechanical device growth hormone treatment assess level adherence subject receive SAIZEN® via easypod™ .</brief_summary>
	<brief_title>To Assess Level Adherence Subjects Receiving SAIZEN® Via Easypod™ Taiwan ( ECOS TWN )</brief_title>
	<detailed_description>Subjects enrol multicenter longitudinal observational study . Parents/subjects provide Informed Consent/assent upload data population-based analysis , ultimately , clinical outcome . Adherence data primarily derive easypod™ device combine physician data entry outcome measure . Data collect retrospectively prospectively . This allow establishment adherence profile explore hypothesis patient adherence support program improve adherence subsequent clinical outcome . Collected data also analyze multinational pooled analysis comparable national study . Primary Objective : • To assess level adherence subject receive SAIZEN® via easypod™ Secondary Objectives : - To describe impact adherence clinical outcome subject receive SAIZEN® via easypod™ - To identify adherence subject profile - To assess impact adherence Insulin-like Growth Factor 1 ( IGF1 ) ( , , within normal range )</detailed_description>
	<mesh_term>Growth Disorders</mesh_term>
	<criteria>Administered growth hormone via easypod™ electromechanical device accord Summary Product Characteristic ( SmPC ) Over age 2 year Under 18 year age , 18 without fusion growth plat Parent 's guardian 's write informed consent , give enter data observational study , understand subject parent/guardian may withdraw consent time without prejudice future medical care . If child old enough read write , separate assent form give defined appropriate jurisdiction country Subjects take growth hormone growth plate fuse ( , take growth hormone 's metabolic effect ) Contraindications SAIZEN® define SmPC Use investigational drug participation another interventional clinical study</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>easypod™</keyword>
	<keyword>SAIZEN®</keyword>
</DOC>